JAN 05, 2017 1:37 PM PST

Study: Chemo Brain Persists for Months After Treatment

WRITTEN BY: Xuan Pham

Chemotherapy is an aggressive attack on the cancer, and on the body. For some women treated with chemo for breast cancer, the effects of chemo seem to reach as far as the brain. The effect, dubbed “chemo brain,” is sparsely known but not deemed as a pervasive side effect of chemotherapy. But now, a new study sheds light on when chemo brain happens and the big impact this effect actually has on the lives of breast cancer patients.

Going through chemotherapy takes a toll on the body and the mind. But for years, doctors and patients focused more on the drugs’ effects on the body. Lapses in mental acuity and memory blurs after chemotherapy were perceived as anecdotal evidence of chemo’s effects in the brain. But it was only recently that researchers really took notice of these reports and linked chemo brain as a side effect of cancer treatment.

But just how pervasive this side effect really is was unknown. To understand this problem, researchers from the University of Rochester Medical Center in New York collected data from 581 breast cancer patients and 364 healthy women. The large sample size makes this one of the largest studies to date to investigate chemo brain.

Led by Michelle Janelsins, the team assessed the women’s cognitive status before, during, and after chemotherapy period. Of note, typical reports of chemo brain include mental fogginess, the inability to concentrate, and general difficulties with cognitive tasks that didn't use to be problematic.

To assess the women’s cognitive changes, the team used the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), a well-known questionnaire that takes into account the patient’s perspective as well as the perspective of others around them.

The findings confirm that chemo brain is indeed quite real. A whopping 45.2 percent of breast cancer showed a decrease in FACT-Cog scores, while only 10.4 percent of healthy women reported any decline. More surprising, the effects seemed to persist even as long as 6 months after the treatment ended. At 6 months post-chemo, 18.4 percent of women with breast cancer still reported “clinically meaningful perceived decline” as compared to only 11.5 percent of control participants.

"Our study, from one of the largest nationwide studies to date, shows that cancer-related cognitive problems are a substantial and pervasive issue for many women with breast cancer,” said Janelsins.

Factors that exacerbate cognitive decline after chemo seem to include symptoms of anxiety and depression before chemotherapy. In addition, cognitive decline seemed to also be correlated with age and race.

“We are currently assessing these data in the context of objective cognitive measures and to understand the role of possible biologic mechanisms that may confer risk to cognitive problems in patients,” said Janelsins. Future studies may also point out if the link between chemotherapy and cognitive decline also includes male cancer patients.

Additional source: University of Rochester Medical Center press release, MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAR 12, 2020
Cell & Molecular Biology
MAR 12, 2020
Zika Virus Used to Treat Advanced Tumors in Dogs
Researchers found a use for the zika virus; they treated advanced tumors of the central nervous system of three elderly ...
MAR 15, 2020
Cell & Molecular Biology
MAR 15, 2020
Immune Cells Can Attack Tumors Remotely
The body's immune system is able to identify the cancerous cells of a tumor and launch an attack against them.
MAR 17, 2020
Cancer
MAR 17, 2020
Cancer and the risk of AFib
Research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of ...
APR 06, 2020
Cancer
APR 06, 2020
A New Lead in the Treatment of Hepatocellular Carcinomas
  Hepatocellular carcinoma, or HCC, is a type of liver cancer, and the third most prevalent cancer-caused death in ...
APR 07, 2020
Cancer
APR 07, 2020
Chemo drugs are leaking into our water
With cancer as the second leading cause of death globally, it comes as a surprise that we know very little up until now ...
APR 17, 2020
Cancer
APR 17, 2020
Can astronauts withstand radiation on a mission to Mars?
New research published in the journal Science Advances attempts to model the risk of cancer that astronauts will incur f ...
Loading Comments...